2. Academic Validation
  3. Regulation of Serine-Threonine Kinase Akt Activation by NAD+-Dependent Deacetylase SIRT7

Regulation of Serine-Threonine Kinase Akt Activation by NAD+-Dependent Deacetylase SIRT7

  • Cell Rep. 2017 Jan 31;18(5):1229-1240. doi: 10.1016/j.celrep.2017.01.009.
Jia Yu 1,  Bo Qin 2,  Fengying Wu 3,  Sisi Qin 1,  Somaira Nowsheen 4,  Shan Shan 5,  Jacqueline Zayas 4,  Huadong Pei 6,  Zhenkun Lou 7,  Liewei Wang 8
Affiliations

Affiliations

  • 1 Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.
  • 2 Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA; Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.
  • 3 Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China.
  • 4 Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic School of Medicine and the Mayo Clinic Medical Scientist Training Program, Rochester, MN 55905, USA.
  • 5 Department of Respiratory Medicine, East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
  • 6 Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA; Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing 100850, China.
  • 7 Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: lou.zhenkun@mayo.edu.
  • 8 Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: wang.liewei@mayo.edu.
PMID: 28147277 DOI: 10.1016/j.celrep.2017.01.009
Abstract

The Akt pathway is a central regulator that promotes cell survival in response to extracellular signals. Depletion of SIRT7, an NAD+-dependent deacetylase that is the least-studied Sirtuin, is known to significantly increase Akt activity in mice through unknown mechanisms. In this study, we demonstrate that SIRT7 depletion in breast Cancer cells results in Akt hyper-phosphorylation and increases cell survival following genotoxic stress. Mechanistically, SIRT7 specifically interacts with and deacetylates FKBP51 at residue lysines 28 and 155 (K28 and K155), resulting in enhanced interactions among FKBP51, Akt, and PHLPP, as well as Akt dephosphorylation. Mutating both lysines to arginines abolishes the effect of SIRT7 on Akt activity through FKBP51 deacetylation. Finally, energy stress strengthens SIRT7-mediated effects on Akt dephosphorylation through FKBP51 and thus sensitizes Cancer cells to cytotoxic agents. These results reveal a direct role of SIRT7 in Akt regulation and raise the possibility of using the glucose analog 2-deoxy-D-glucose (2DG) as a chemo-sensitizing agent.

Keywords

Akt signaling pathway; SIRT7; breast cancer; chemo-sensitivity.

Figures